U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc. Already, Pfizer and Moderna are shipping shots modified to better match more recent strains of the ever-evolving coronavirus. Friday, the Food and Drug Administration gave the OK to the updated Novavax formula, too — and those shots are open to anyone 12 and older.
Despite becoming one a household name during the pandemic, Moderna stock has mostly fallen over the past three years amid slow sales.
We recently compiled a list of the 10 Best Medical AI Companies. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other medical AI companies. The Need for AI in Healthcare Generally, when you hear the term “artificial intelligence,” your mind jumps straight to semiconductor and big […]